Gallbladder disease in Shetland Sheepdogs: 38 Cases (1995-2005)

Journal of the American Veterinary Medical Association

Volumn 231, Issue 1, 2007, Pages 79-88

  Aguirre, Ale L ^a,c   Center, Sharon A ^a   Randolph, John E ^a   Yeager, Amy E ^a   Keegan, Alicia M ^b   Harvey, H Jay ^a   Erb, Hollis N ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Lake Veterinary Hospital   (United States)

^c RED BANK VETERINARY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE CONTROL STUDY; DOG; DOG DISEASE; FEMALE; GALLBLADDER; GALLBLADDER DISEASE; LIVER DISEASE; MALE; MUCOCELE; PANCREATITIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; GALLBLADDER; GALLBLADDER DISEASES; LIVER DISEASES; MALE; MUCOCELE; PANCREATITIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 34347338704     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.1.79     Document Type: Article

References (48)

1. Newell SM, Selcer BA, Mahaffey MB, et al. Gallbladder mucocele causing biliary obstruction in two dogs: ultrasonographic, scintigraphic, and pathological findings. J Am Anim Hosp Assoc 1995;31:467-472.
2. Besso JG, Wrigley RH, Gliatto JM, et al. Ultrasonographic appearance and clinical findings in 14 dogs with gallbladder mucocele. Vet Radiol Ultrasound 2000;41:261-271.
3. Pike FS, Berg J, King NW, et al. Gallbladder mucocele in dogs: 30 cases (2000-2002). J Am Vet Med Assoc 2004;224:1615-1622.
4. Worley DR, Hottinger HA, Lawrence HJ. Surgical management of gallbladder mucoceles in dogs: 22 cases (1999-2003). J Am Vet Med Assoc 2004;225:1418-1422.
5. Angelico M, DeSantis A, Capocaccia L. Biliary sludge: a critical update. J Clin Gastroenterol 1990;12:656-662.
6. Boland LL, Folsom AR, Rosamond WD. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: a prospective study. Ann Epidemiol 2002;12:131-140.
7. Rogers WA, Donovan EE, Kociba GJ. Idiopathic hyperlipoproteinemia in dogs. J Am Vet Med Assoc 1975;166:1087-1091.
8. Whitney MS, Boon GD, Rebar AH, et al. Ultracentrifugal and electrophoretic characteristics of the plasma lipoproteins of miniature schnauzer dogs with idiopathic hyperlipoproteinemia. J Vet Intern Med 1993;7:253-260.
9. Sato K, Agoh H, Kaneshige T, et al. Hypercholesterolemia in Shetland sheepdogs. J Vet Med Sci 2000;62:1297-1301.
10. Kovatch RM, Hilderbrandt PK, Marcus LC. Cystic mucinous hypertrophy of the mucosa of the gall bladder in the dog. Vet Pathol 1965;2:574-584.
11. Lee SP, Nicholls JF. Nature and composition of biliary sludge. Gastroenterology 1988;90:677-686.
12. Ko CO, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med 1999;130:301-311.
13. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1986;90:170-176.
14. Lichtenstein GR, Dabezies MA. Biliary tract dysmotility. Curr Treat Options Gastroenterol 1998;1:27-34.
15. Portincasa P, DiCiaula A, vanBerge-Henegouwen GP. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 2004;6:151-162.
16. Brand B, Lerche L, Stange EF. Symptomatic or asymptomatic gallstone disease: is the gallbladder motility the clue? Hepatogastroenterology 2002;49:1208-1212.
17. Zajko AB, Bennett MJ, Campbell WL, et al. Mucocele of the cystic duct remnant in eight liver transplant recipients: findings at cholangiography, CT, and US. Radiology 1990;177:691-693.
18. Koneru B, Zajko AB, Sher L, et al. Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet 1989;168:394-396.
19. Dodds WJ, Groh WJ, Darweesh RMA, et al. Sonographic measurement of gallbladder volume. Am J Roentgenol 1985;145:1009-1011.
20. Barr RG, Agnesi JN, Schaub CR. Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults. Radiology 1997;204:105-111.
21. Priester WA, Adelstein EH, Peters JA, eds. Standard nomenclature of veterinary diseases and operations. DHEW publication No. 1466. Washington, DC: US Government Printing Office, 1966.
22. Finn-Bodner ST, Park RD, Tyler JW, et al. Ultrasonographic determination, in vitro and in vivo, of canine gallbladder volume, using four volumetric formulas and stepwise-regression models. Am J Vet Res 1993;54:832-835.
23. Jonderko K, Ferre JP, Bueno L. Real-time ultrasonography as a noninvasive tool for the examination of canine gallbladder emptying: a validation study. J Pharmacol Toxicol Methods 1992;27:107-111.
24. Sterczer A, Voros K, Karsai F. Effect of cholagogues on the volume of the gallbladder of dogs. Res Vet Sci 1996;60:44-47.
25. Ko CW, Schulte SJ, Lee SP. Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa. Clin Gastroenterol Hepatol 2005;3:672-678.
26. Moser AJ, Abedin MZ, Cates JA, et al. Converting gallbladder absorption to secretion: the role of intracellular calcium. Surgery 1996;119:410-416.
27. Dawes LG, Nahrwold DL, Rege RV. Increased total and free ionized calcium in a canine model of pigment gallstones. Surgery 1988;104:86-90.
28. Dawes LG, Nahrwold DL, Rege RV. Supersaturation of canine gallbladder bile with calcium bilirubinate during formation of pigment gallstones. Am J Surg 1989;157:82-88.
29. Dawes LG, Nahrwold DL, Roth SI, et al. Reversal of pigment gallstone disease in a canine model. Arch Surg 1989;124:463-466.
30. Jungst D, Niemeyer A, Muller I, et al. Mucin and phospholipids determine viscosity of gallbladder bile in patients with gallstones. World J Gastroenterol 2001;7:203-207.
31. LaMont JT, Smith BF, Moore JR. Role of gallbladder mucin in pathophysiology of gallstones. Hepatology 1984;Suppl 5:51S-56S.
32. Lee SP. Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholithiasis. J Pathol 1981;134:199-207.
33. Sheen PC, Lee KT, Liu YE. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periphery. Digestion 1998;59:660-664.
34. Rege RV, Prystowsky JB. Inflammatory properties of bile from dogs with pigment gallstones. Am J Surg 1996;171:197-201.
35. Lamote J, Willems G. DNA synthesis, cell proliferation index in normal and abnormal gallbladder epithelium. Microsc Res Tech 1997;38:609-615.
36. Klinkspoor JH, Kuver R, Savard CE, et al. Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology 1995;109:264-274.
37. Mawdesley-Thomas LE, Noel PR. Cystic hyperplasia of the gall bladder in the beagle, associated with the administration of progestational compounds. Vet Rec 1967;80:658-659.
38. Geil RG, Lamar JK. FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey. J Toxicol Environ Health 1977;3:179-193.
39. Selman PJ, van Garderen E, Mol JA, et al. Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone. Vet Q 1995;17:128-133.
40. Niebergall-Roth E, Teyessen S, Singer MV. Neurohormonal control of gallbladder motility. Scand J Gastroenterol 1997;32:737-750.
41. Shaffer EA. Review article: control of gall-bladder motor function. Aliment Pharmacol Ther 2000;14(suppl 2):2-8.
42. Tomida S, Abei M, Yamaguchi T, et al. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999;97:726-731.
43. Kano M, Shoda J, Irimura T, et al. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipase A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. Hepatology 1998;28:302-313.
44. Fischer S, Muller I, Zundt BZ, et al. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. Eur J Gastroenterol Hepatol 2004;16:305-311.
45. Ballatori N, Rebbeor JF. Roles of MRP2 andoatpl in hepatocellular export of reduced glutathione. Semin Liver Dis 1998;18:377-387.
46. Center SA, Randolph JF, Warner KL, et al. The effects of S-adenosylmethionine on clinical pathology and redox potential in the red blood cell, liver, and bile of clinically normal cats. J Vet Intern Med 2005;19:303-314.
47. Center SA, Warner KL, Erb HN. Liver glutathione concentrations in dogs and cats with naturally occurring liver disease. Am J Vet Res 2002;63:1187-1197.
48. Muriel P, Suarez OR, Gonzalez P, et al. Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994;21:95-102.